Always putting healthier
lives first
scroll
News
-
Integrated Report 2023 has been released
-
Sawai Group Holdings Announces Change of Representative Directors and Corporate Officers
-
Sawai Group Reports First Half of Quarter FY2022 Financial Results
-
Sawai Group Reports First Quarter FY2022 Financial Results
-
Sawai Group Reports FY2021 Financial Results
-
Launch of Pitavastatin tablets in the United States – Sawai’s First generic ANDA approval and launch for US market under Paragraph IV–
-
Upsher-Smith Expands Generics Portfolio with Launch of Mesalamine Extended-Release Capsules, USP
-
Upsher-Smith Expands Vigadrone® (vigabatrin) Franchise to Include Tablets
-
Upsher-Smith Launches Isotretinoin Capsules, USP
-
Upsher-Smith Completes Sale of Two Migraine Products
Company Information
